BINA Daily: AI and Health — 2026-10-22

        October 22, 2026

BINA Daily: AI and Health — 2026-10-22

BINA DAILY · 2026-10-22

Today: AI policy and product news, plus the latest in health and medicine.

BINA DAILY · 2026-10-22

AI BRIEF

AI Brief: OpenAI on Google Cloud, NVIDIA Capacity Surge, xAI's $7.56B Quarter, Meta Investor Jitters, US State AI Laws
OpenAI joins Google Cloud's Model Garden, NVIDIA doubles down on supply chain, xAI hits $7.56B, Meta faces investor pressure, and US states act on AI policy.
IN TODAY'S BRIEF

OpenAI Models Land on Google Cloud's Model Garden
NVIDIA Commits to Massive Supply Chain Expansion
xAI Posts $7.56 Billion Q3 Revenue—Over 800% Growth
Meta's AI Spending Draws Investor Scrutiny
US States Push Forward on AI Regulation

Read the full AI brief →

HEALTH ROUNDUP

AI Takes Center Stage in Clinical Trials, Drug Discovery, and FDA Regulation
AstraZeneca-Oracle partner on AI trials, FDA nears GenAI guidance, and a wave of drug discovery deals signals a maturing market.
IN TODAY'S BRIEF

AstraZeneca and Oracle Launch Global AI Platform for Clinical Trials
FDA Receives Over 500 Responses to GenAI Medical Device Framework
FDA Director Confirms Draft Generative AI Guidance Coming Within Months
AI Drug Discovery Deals Surge: AstraZeneca-insitro, Zealand-Generate, and Iambic's IPO
Abu Dhabi Future Health Summit: Sensing, Predicting, and Acting Earlier

Read the full health roundup →

BINA CYINNOVATION HUB · Larnaca · est. 2026

Unsubscribe

                                Don't miss what's next. Subscribe to Bina CyInnovation Daily Update:

                        Email
                        *

                    ← Newer

                BINA יומי: AI ובריאות — 2026-10-22

                    Older →

                BINA יומי: AI ובריאות — 2026-10-21